• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

Clinical Ethical Governance of Generative Medical Artificial Intelligence (GMAI): A Three-Dimensional Collaborative Pathway and Chinese Practices

Corresponding author: Dai hui, 13889903995@139.com
DOI: 10.12201/bmr.202511.00057
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Purpose/SignificanceThis study aims to address core ethical challenges such as algorithmic black boxes and ambiguous liability in the clinical application of Generative Medical Artificial Intelligence (GMAI), construct an ethical governance system adapted to China’s healthcare context, and provide theoretical support and practical references for balancing GMAI technological innovation with ethical constraints to promote the high-quality development of medical AI.Methods/ProcessBased on the characteristics of China’s healthcare system, data ecosystem, and cultural context, this paper compares differences in GMAI governance scenarios between China and other countries. A three-dimensional collaborative governance framework (technology, institution, and society) is established, with a detailed analysis of the responsibilities of multiple stakeholders including patients, physicians, and technology platforms. Key practical pathways such as federated learning, hierarchical supervision, and ethical sandboxes are elaborated.Results/ConclusionsA three-dimensional collaborative governance scheme for GMAI clinical ethics is proposed: technological security guarantee - dynamic institutional regulation - multi-stakeholder social governance. At the technical level, federated learning enables secure data sharing; at the institutional level, a hierarchical supervision mechanism of strict control for high-risk applications and flexible management for low-risk ones is established; at the social level, ethical sandboxes and multi-stakeholder governance models are integrated. This scheme effectively responds to the specific needs of GMAI governance in the Chinese context and provides replicable Chinese practices for global medical AI ethical governance. Future efforts should focus on bridging the digital divide at the grassroots level and optimizing the judicial connection of dynamic liability mechanisms.

    Key words: AI medical ethics; federal learning; gradient penetration governance; dynamic responsibility mechanism; Chinese practice

    Submit time: 20 November 2025

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • shisenzhong. Analysis of the Risks and Governance Strategies for the Application of Generative Artificial Intelligence (GAI) in Primary Healthcare. 2024. doi: 10.12201/bmr.202408.00053

    Meng Dongqing, LV Wenjuan. Research on the Path of Constructing Knowledge Services in Medical Libraries Empowered by Generative Artificial Intelligence. 2025. doi: 10.12201/bmr.202510.00039

    Huanghanqi, Zhoumanci, Yanghuiwen, Wangruizhi, Wangruojia. A Study of Ethical Risks of Medical Artificial Intelligence Applications from the Perspective of the Public in Society. 2025. doi: 10.12201/bmr.202511.00062

    Wang Qian, Liu Xiangmin, Chen Lingyun, Fang An. Roadmap of Data Governance to Artificial Intelligence in National Institutes of Health. 2025. doi: 10.12201/bmr.202505.00026

    The Practice-Based Education Mechanism of Comprehensive Ideological and Political Education in Medical Institutions Under Collaborative Governance. 2025. doi: 10.12201/bmr.202512.00040

    Exploration of Medical Video Creation Path Based on Generative Artificial Intelligence. 2025. doi: 10.12201/bmr.202508.00005

    阮晓龙. Exploration and Practice of the Construction of Intelligent Medical Engineering Major in Traditional Chinese Medicine Colleges under the Industry-Education-Research-Medical Collaborative Education Mechanism. 2025. doi: 10.12201/bmr.202511.00007

    zhaorui, shixiuyuan, zhongxueran, renping, tianxueqin, liuchunping, youmao. Construction of clinical application evaluation path of medical artificial intelligence technology based on health technology evaluationRui Zhao, Xiuyuan Shi, Xueran Zhong, Chunping Liu, Ping Ren, Xueqin Tian, Mao You. 2022. doi: 10.12201/bmr.202203.00005

    litao, fenghexia. Innovative Applications, Risk Challenges, and Governance Countermeasures of Artificial Intelligence in the Healthcare Industry. 2025. doi: 10.12201/bmr.202501.00067

    XIANG AININGKUN, TIAN JINGXUE, HU DEHUA, LIU HAIXIA. Comparative Study on Response Efficacy of Generative Artificial Intelligence for Elderly Diabetes Mellitus. 2025. doi: 10.12201/bmr.202503.00019

  • ID Submit time Number Download
    1 2025-08-30

    10.12201/bmr.202511.00057V1

    Download
  • Public  Anonymous  To author only

Get Citation

Li Yuhang, Dai hui. Clinical Ethical Governance of Generative Medical Artificial Intelligence (GMAI): A Three-Dimensional Collaborative Pathway and Chinese Practices. 2025. biomedRxiv.202511.00057

Article Metrics

  • Read: 208
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误